Results 151 to 160 of about 1,266,387 (240)

The relationship between resilience, financial toxicity, and quality of life in patients with primary liver cancer: a cross-sectional study. [PDF]

BMC Gastroenterol
Mao Z, Qian H, Liu R, Huo R.
europepmc   +1 more source

Global research trends and hotspots on environmental pollution and primary liver cancer: a bibliometric and visualized analysis. [PDF]

Trop Med Health
Hu J, Jiao X, Wang Y, Yang H, Zhang X, Jiang F, Li P.   +6 more
europepmc   +1 more source

Noninvasive imaging analysis of vascular phenotypes improves prognostic stratification in primary liver cancer: a multi-cohort study. [PDF]

NPJ Precis Oncol
Xin H, Wang Y, Xin H, Lai Q, Wang X, Wang H, Hu J, Zhang Y, Zhou K, Liao B, Bai Y, Chen Z.   +11 more
europepmc   +1 more source

Analysis of survival prognosis and influencing factors in patients with primary liver cancer after D-TACE: a retrospective cohort study. [PDF]

BMC Gastroenterol
Zhang L, Yuan J, Liu S, Zhang L, Ma LN, Xialuo, Ding X.   +6 more
europepmc   +1 more source

Diagnosis and treatment of hemothorax following local ablation in patients with primary liver cancer. [PDF]

BMC Gastroenterol
Lu N, Yuan C, Li J, Sun B, Shi Q, Gao W, Ma L, Zhang Y.   +7 more
europepmc   +1 more source

Hepatic resections for metastatic tumors [PDF]

, 1989
Iwatsuki, S, Starzl, TE
core  

Effects of Lenvatinib combined with immune checkpoint inhibitors on efficacy, immune function and prognosis in patients with primary liver cancer. [PDF]

Pak J Med Sci
Hou Y, Gao Z, Liu C, Zhang Y, Zhang D.
europepmc   +1 more source

Iatrogenic Alterations of Immunologic Surveillance in Man and Their Influence on Malignancy [PDF]

, 1971
Agosin M., Albert D., Alford T. C, Allison A. C, Alpert E., Alpert M. E., Anigsten L., Bach F. H., Baserga R., Bekkum D. W., Berman C., Bortin M. M., Bremberg S., Burnet F. M., Burnet F. M., Burnet F. M., Burnet F. M., Casey T. P., Davis R. C., Dent P. B., Deodhar S. D., Doak P. B., Doll R., Epstein R. B., Fisher E. R., Foley E. J., Foley E. J., Fortner J. G., Grant G. A., Gustafson E. G., Hellman K., Hirsch M. S., Huber J., Immunology and Cancer, Isojima S., Jensen C O., Kay S., Law L. W., MacLean L. D., Mandel M.A., Marchioro T. L., Martin D. C, Martinez C, Mathe G., Mathe G., McIntosh D. A., McKhann C. F., Miller J. F. A. P., Moore G. E., Muizniks H. W., Page A. R., Penn I., Penn I., Penn I., Penn I., Prehn R. T., Pritzker K. P. H., Rabbat A. G., Santos G. W., Santos G. W., Schwartz R., Simmons R. L., Sjogren H. O., Snell G. D., Southam C. M., Speck B., Starzl T. E., Starzl T. E., Starzl T. E., Starzl T. E., Starzl T. E., Starzl T. E., Starzl T. E., Starzl T. E., Starzl T. E., Starzl T. E., Tallent M. B., Thomas L., Toolan H.W., Tunner W. S., Tyler A., Vredevoe D. L., Weiler E., Wilson R. E., Zukoski C. F., Zukoski C. F.   +85 more
core   +1 more source

Case Report: Treatment with magnetic nanoparticle-based hyperthermia stabilizes metastatic disease in stage IV primary liver cancer patients. [PDF]

Front Oncol
Kraus S, Arbib S, Ventura-Bixenshpaner H, Rukenstein P, Hirsh-Kovacs M, Shalev B, Eltanani M, Ron U, Gumina O, Shalev O, Geschwind J.   +10 more
europepmc   +1 more source

Efficacy and safety of AiDi injection in treating primary liver cancer: a systematic review on 70 randomized controlled trials. [PDF]

Sci Rep
Duan Z, Mo X, Jia L, Li H, Liang X, Jin S, Jia Y.   +6 more
europepmc   +1 more source